What top creators are saying about Chemomab Therapeutics Ltd.(CHYM)
Clinical-stage biopharmaceutical company
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Not enough scored insights about Chemomab Therapeutics Ltd. in the last 30 days yet.
Top creators covering Chemomab Therapeutics Ltd. (CHYM)
The 1 sources with the most insights about Chemomab Therapeutics Ltd. on Kazuha.
Latest insights about Chemomab Therapeutics Ltd. (CHYM)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Wednesday, January 7, 2026
Recent statements from CHYM at conferences suggest no consumer weakness, contrary to public sentiment, indicating potential for underestimated consumer strength.
Wednesday, January 7, 2026
Recent statements from CHYM at conferences suggest no consumer weakness, contrary to public sentiment, indicating potential for underestimated consumer strength.
Discussed alongside Chemomab Therapeutics Ltd. (CHYM)
Other assets that creators frequently mention in the same content as Chemomab Therapeutics Ltd..
Frequently asked
Which podcasters and creators cover Chemomab Therapeutics Ltd. (CHYM) the most?
The most active sources covering Chemomab Therapeutics Ltd. (CHYM) on Kazuha are beaniemaxi. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Chemomab Therapeutics Ltd. (CHYM) are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about Chemomab Therapeutics Ltd. (CHYM) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Chemomab Therapeutics Ltd. (CHYM)?
Creators covering Chemomab Therapeutics Ltd. (CHYM) most frequently also discuss KLAR, CDLX. See the "Discussed alongside" section above for full asset pages.